Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Janetta Lynne Iwanicki

TitleAffiliate - DHHA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-EM MED Clinical

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA? ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527. PMID: 37850331.
      View in: PubMed
    2. Black JC, Burkett HL, Rockhill KM, Olson R, Dart RC, Iwanicki J. Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis. J Med Internet Res. 2023 10 05; 25:e46747. PMID: 37796607.
      View in: PubMed
    3. Rockhill KM, Olson R, Dart RC, Iwanicki JL, Black JC. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. J Med Internet Res. 2023 09 20; 25:e46742. PMID: 37728974.
      View in: PubMed
    4. Severtson SG, Gurrola MC, Parrino MW, Ellis MS, Cicero TJ, Iwanicki JL, Dart RC. Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders. J Opioid Manag. 2023 Sep-Oct; 19(5):445-453. PMID: 37968978.
      View in: PubMed
    5. Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. Correction to: A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 May; 43(5):379. PMID: 37040042.
      View in: PubMed
    6. Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 Mar; 43(3):197-203. PMID: 36859697.
      View in: PubMed
    7. Black JC, Amioka E, Iwanicki JL, Dart RC, Monte AA. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks. JAMA Netw Open. 2022 11 01; 5(11):e2240526. PMID: 36342719.
      View in: PubMed
    8. Mutter R, Black J, Iwanicki J. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Psychiatr Serv. 2023 01 01; 74(1):63-65. PMID: 35770425.
      View in: PubMed
    9. Palamar JJ, Cottler LB, Goldberger BA, Severtson SG, Grundy DJ, Iwanicki JL, Ciccarone D. Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021. Am J Drug Alcohol Abuse. 2022 07 04; 48(4):471-480. PMID: 35704785.
      View in: PubMed
    10. Fischer LJ, Severtson SG, Gurrola MC, Iwanicki JL, Green JL, Dart RC. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014. Subst Use Misuse. 2022; 57(7):1097-1103. PMID: 35450512.
      View in: PubMed
    11. Black JC, Rockhill KM, Dart RC, Iwanicki J. Clustering patterns in polysubstance mortality in the United States in 2017: a multiple correspondence analysis of death certificate data. Ann Epidemiol. 2023 01; 77:119-126. PMID: 35378292.
      View in: PubMed
    12. Hockenhull J, Wood DM, Fonseca F, Guareschi M, Scherbaum N, Iwanicki JL, Dart RC, Dargan PI. The association between the availability of over the counter codeine and the prevalence of non-medical use. Eur J Clin Pharmacol. 2022 Jun; 78(6):1011-1018. PMID: 35244726.
      View in: PubMed
    13. Black J, Margolin ZR, Bau G, Olson R, Iwanicki JL, Dart RC. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study. JMIR Public Health Surveill. 2021 12 20; 7(12):e29187. PMID: 34932012.
      View in: PubMed
    14. Black JC, Forber A, Severtson SG, Rockhill K, May KP, Amioka E, Schwarz J, Iwanicki J, Dart RC. Drug product dispensing and estimates of use in a general population survey as a signal detection problem. Pharmacoepidemiol Drug Saf. 2021 08; 30(8):1132-1139. PMID: 33931917.
      View in: PubMed
    15. Black JC, Bau GE, Iwanicki JL, Dart RC. Association of Medical Stimulants With Mortality in the US From 2010 to 2017. JAMA Intern Med. 2021 05 01; 181(5):707-709. PMID: 33523100.
      View in: PubMed
    16. Dart RC, Iwanicki JL, Black JC, Olsen HA, Severtson SG. Measuring prescription opioid misuse and its consequences. Br J Clin Pharmacol. 2021 04; 87(4):1647-1653. PMID: 33606888.
      View in: PubMed
    17. Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020 12 25; 21(12):3660-3668. PMID: 33094329.
      View in: PubMed
    18. Iwanicki JL, Schwarz J, May KP, Black JC, Dart RC. Tramadol non-medical use in Four European countries: A comparative analysis. Drug Alcohol Depend. 2020 12 01; 217:108367. PMID: 33153831.
      View in: PubMed
    19. Schimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JL. Kratom use in the United States: Response to Grundmann et al. Addiction. 2021 01; 116(1):203-204. PMID: 32588454.
      View in: PubMed
    20. Schimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JL. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2021 01; 116(1):176-181. PMID: 32285981.
      View in: PubMed
    21. Iwanicki JL, Severtson SG, Margolin Z, Dasgupta N, Green JL, Dart RC. Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016. Am J Public Health. 2018 12; 108(12):1639-1645. PMID: 30403501.
      View in: PubMed
    22. Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Do abuse deterrent opioid formulations work? J Opioid Manag. 2017 Nov/Dec; 13(6):365-378. PMID: 29308584.
      View in: PubMed
    23. Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLoS One. 2016; 11(12):e0167499. PMID: 27936038.
      View in: PubMed
    24. Chua-Tuan JL, Cao D, Iwanicki JL, Hoyte CO. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report. Clin Toxicol (Phila). 2015 Jul; 53(6):565-8. PMID: 25951877.
      View in: PubMed
    25. Monte AA, Bronstein AC, Cao DJ, Heard KJ, Hoppe JA, Hoyte CO, Iwanicki JL, Lavonas EJ. An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med. 2014 Jan 23; 370(4):389-90. PMID: 24450915.
      View in: PubMed
    26. Iwanicki JL, Lu KW, Taeusch HW. Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan. Exp Lung Res. 2010 Apr; 36(3):167-74. PMID: 20334607.
      View in: PubMed
    Iwanicki's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (106) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)